Substrates of the Methionine Sulfoxide Reductase System and Their Physiological Relevance

Current Topics in Developmental Biology

Volumn 80, Issue , 2007, Pages 93-133

  Oien, Derek B ^a   Moskovitz, Jackob ^a  

^a UNIVERSITY OF KANSAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG DERIVATIVE; ENZYME; HORMONE; METHIONINE; METHIONINE SULFOXIDE; METHIONINE SULFOXIDE REDUCTASE; OXIDOREDUCTASE; SCAVENGER; SERINE PROTEINASE INHIBITOR;

ANIMAL; ATHEROSCLEROSIS; BIOLOGICAL MODEL; DEGENERATIVE DISEASE; ENZYME SPECIFICITY; HUMAN; METABOLISM; OXIDATION REDUCTION REACTION; REVIEW;

ANIMALS; ATHEROSCLEROSIS; ENZYMES; FREE RADICAL SCAVENGERS; HORMONES; HUMANS; METHIONINE; MODELS, BIOLOGICAL; NEURODEGENERATIVE DISEASES; OXIDATION-REDUCTION; OXIDOREDUCTASES; SERPINS; SUBSTRATE SPECIFICITY;

EID: 35348903730     PISSN: 00702153     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0070-2153(07)80003-2     Document Type: Review

References (166)

1. Abrams W.R., Weinbaum G., Weissbach L., Weissbach H., and Brot N. Enzymatic reduction of oxidized alpha-1-proteinase inhibitor restores biological activity. Proc. Natl. Acad. Sci. USA 78 (1981) 7483-7486
2. Alamuri P., and Maier R.J. Methionine sulphoxide reductase is an important antioxidant enzyme in the gastric pathogen Helicobacter pylori. Mol. Microbiol. 53 (2004) 1397-1406
3. Alamuri P., and Maier R.J. Methionine sulfoxide reductase in Helicobacter pylori: Interaction with methionine-rich proteins and stress-induced expression. J. Bacteriol. 188 (2006) 5839-5850
4. Amiconi G., Ascoli F., Barra D., Bertollini A., Matarese R.M., Verzili D., and Brunori M. Selective oxidation of methionine beta(55)D6 at the alpha 1 beta 1 interface in hemoglobin completely destabilizes the T-state. J. Biol. Chem. 264 (1989) 17745-17749
5. Anantharamaiah G.M., and Garber D.W. Chromatographic methods for quantitation of apolipoprotein A-I. Methods Enzymol. 263 (1996) 267-282
6. Anantharamaiah G.M., Hughes T.A., Iqbal M., Gawish A., Neame P.J., Medley M.F., and Segrest J.P. Effect of oxidation on the properties of apolipoproteins A-I and A-II. J. Lipid Res. 29 (1988) 309-318
7. Antonini G., and Spoto G. Reversed phase high performance liquid chromatography of adrenocorticotropin 1-39 and its fragments in the native and oxidized forms. Biochem. Int. 16 (1988) 1009-1017
8. Balog E.M., Norton L.E., Bloomquist R.A., Cornea R.L., Black D.J., Louis C.F., Thomas D.D., and Fruen B.R. Calmodulin oxidation and methionine to glutamine substitutions reveal methionine residues critical for functional interaction with ryanodine receptor-1. J. Biol. Chem. 278 (2003) 15615-15621
9. Balog T., Sobocanec S., Sverko V., and Marotti T. Met-enkephalin modulates resistance to oxidative stress in mouse brain. Neuropeptides 38 (2004) 298-303
10. Bar-Noy S., and Moskovitz J. Mouse methionine sulfoxide reductase B: Effect of selenocysteine incorporation on its activity and expression of the seleno-containing enzyme in bacterial and mammalian cells. Biochem. Biophys. Res. Commun. 297 (2002) 956-961
11. Baraban S.C. Neuropeptide Y and epilepsy: Recent progress, prospects and controversies. Neuropeptides 38 (2004) 261-265
12. Barnham K.J., Ciccotosto G.D., Tickler A.K., Ali F.E., Smith D.G., Williamson N.A., Lam Y.H., Carrington D., Tew D., Kocak G., Volitakis I., Separovic F., et al. Neurotoxic, redox-competent Alzheimer's beta-amyloid is released from lipid membrane by methionine oxidation. J. Biol. Chem. 278 (2003) 42959-42965
13. Bartlett R.K., Bieber Urbauer R.J., Anbanandam A., Smallwood H.S., Urbauer J.L., and Squier T.C. Oxidation of Met144 and Met145 in calmodulin blocks calmodulin dependent activation of the plasma membrane Ca-ATPase. Biochemistry 42 (2003) 3231-3238
14. Beddell C.R., Clark R.B., Hardy G.W., Lowe L.A., Ubatuba F.B., Vane J.R., and Wilkinson S. Structural requirements for opioid activity of analogues of the enkephalins. Proc. R. Soc. Lond. B Biol. Sci. 198 (1977) 249-265
15. Biewenga G.P., Veening-Griffioen D.H., Nicastia A.J., Haenen G.R., and Bast A. Effects of dihydrolipoic acid on peptide methionine sulfoxide reductase. Implications for antioxidant drugs. Arzneimittelforschung 48 (1998) 144-148
16. Bigelow D.J., and Squier T.C. Redox modulation of cellular signaling and metabolism through reversible oxidation of methionine sensors in calcium regulatory proteins. Biochim. Biophys. Acta 1703 (2005) 121-134
17. Boudier C., and Bieth J.G. Oxidized mucus proteinase inhibitor: A fairly potent neutrophil elastase inhibitor. Biochem. J. 303 Pt. 1 (1994) 61-68
18. Breydo L., Bocharova O.V., Makarava N., Salnikov V.V., Anderson M., and Baskakov I.V. Methionine oxidation interferes with conversion of the prion protein into the fibrillar proteinase K-resistant conformation. Biochemistry 44 (2005) 15534-15543
19. Brock J.W., Ames J.M., Thorpe S.R., and Baynes J.W. Formation of methionine sulfoxide during glycoxidation and lipoxidation of ribonuclease A. Arch. Biochem. Biophys. 457 (2007) 170-176
20. Brot N., and Weissbach H. Peptide methionine sulfoxide reductase: Biochemistry and physiological role. Biopolymers 55 (2000) 288-296
21. Brot N., Weissbach L., Werth J., and Weissbach H. Enzymatic reduction of protein-bound methionine sulfoxide. Proc. Natl. Acad. Sci. USA 78 (1981) 2155-2158
22. Brouillette C.G., Anantharamaiah G.M., Engler J.A., and Borhani D.W. Structural models of human apolipoprotein A-I: A critical analysis and review. Biochim. Biophys. Acta 1531 (2001) 4-46
23. Buijs R.M., van Eden C.G., Goncharuk V.D., and Kalsbeek A. The biological clock tunes the organs of the body: Timing by hormones and the autonomic nervous system. J. Endocrinol. 177 (2003) 17-26
24. Butt A.M., and Kalsi A. Inwardly rectifying potassium channels (Kir) in central nervous system glia: A special role for Kir4.1 in glial functions. J. Cell. Mol. Med. 10 (2006) 33-44
25. Caldwell P., Luk D.C., Weissbach H., and Brot N. Oxidation of the methionine residues of Escherichia coli ribosomal protein L12 decreases the protein's biological activity. Proc. Natl. Acad. Sci. USA 75 (1978) 5349-5352
26. Carlsson F.H., and Louw A.I. The oxidation of methionine and its effect of the properties of cardiotoxin VII1 from Naja melanoleuca venom. Biochim. Biophys. Acta 534 (1978) 322-330
27. Carp H., and Janoff A. Inactivation of bronchial mucous proteinase inhibitor by cigarette smoke and phagocyte-derived oxidants. Exp. Lung Res. 1 (1980) 225-237
28. Chao C.C., Ma Y.S., and Stadtman E.R. Modification of protein surface hydrophobicity and methionine oxidation by oxidative systems. Proc. Natl. Acad. Sci. USA 94 (1997) 2969-2974
29. Chen J., Avdonin V., Ciorba M.A., Heinemann S.H., and Hoshi T. Acceleration of P/C-type inactivation in voltage-gated K(+) channels by methionine oxidation. Biophys. J. 78 (2000) 174-187
30. Chen Y.R., Deterding L.J., Sturgeon B.E., Tomer K.B., and Mason R.P. Protein oxidation of cytochrome C by reactive halogen species enhances its peroxidase activity. J. Biol. Chem. 277 (2002) 29781-29791
31. Choi J., Sullards M.C., Olzmann J.A., Rees H.D., Weintraub S.T., Bostwick D.E., Gearing M., Levey A.I., Chin L.S., and Li L. Oxidative damage of DJ-1 is linked to sporadic Parkinson and Alzheimer diseases. J. Biol. Chem. 281 (2006) 10816-10824
32. Chu S.T., Chu C.C., Tseng C.C., and Chen Y.H. Met-8 of the beta 1-bungarotoxin phospholipase A2 subunit is essential for the phospholipase A2-independent neurotoxic effect. Biochem. J. 295 Pt. 3 (1993) 713-718
33. Ciorba M.A., Heinemann S.H., Weissbach H., Brot N., and Hoshi T. Modulation of potassium channel function by methionine oxidation and reduction. Proc. Natl. Acad. Sci. USA 94 (1997) 9932-9937
34. + channels by methionine oxidation: Effect of nitric oxide and vitamin C. FEBS Lett. 442 (1999) 48-52
35. Cutruzzola F., Ascenzi P., Barra D., Bolognesi M., Menegatti E., Sarti P., Schnebli H.P., Tomova S., and Amiconi G. Selective oxidation of Met-192 in bovine alpha-chymotrypsin. Effect on catalytic and inhibitor binding properties. Biochim. Biophys. Acta 1161 (1993) 201-208
36. DalleDonne I., Milzani A., and Colombo R. The tert-butyl hydroperoxide-induced oxidation of actin Cys-374 is coupled with structural changes in distant regions of the protein. Biochemistry 38 (1999) 12471-12480
37. Dalle-Donne I., Rossi R., Giustarini D., Gagliano N., Di Simplicio P., Colombo R., and Milzani A. Methionine oxidation as a major cause of the functional impairment of oxidized actin. Free Radic. Biol. Med. 32 (2002) 927-937
38. Dalle-Donne I., Aldini G., Carini M., Colombo R., Rossi R., and Milzani A. Protein carbonylation, cellular dysfunction, and disease progression. J. Cell. Mol. Med. 10 (2006) 389-406
39. Davis D.A., Newcomb F.M., Moskovitz J., Wingfield P.T., Stahl S.J., Kaufman J., Fales H.M., Levine R.L., and Yarchoan R. HIV-2 protease is inactivated after oxidation at the dimer interface and activity can be partly restored with methionine sulphoxide reductase. Biochem. J. 346 Pt. 2 (2000) 305-311
40. Davis D.A., Newcomb F.M., Moskovitz J., Fales H.M., Levine R.L., and Yarchoan R. Reversible oxidation of HIV-2 protease. Methods Enzymol. 348 (2002) 249-259
41. De la Llosa P., El Abed A., and Roy M. Oxidation of methionine residues in lutropin. Can. J. Biochem. 58 (1980) 745-748
42. Dedman M.L., Farmer T.H., and Morris C.J. Studies on pituitary adrenocorticotrophin. 3. Identification of the oxidation-reduction centre. Biochem. J. 78 (1961) 348-352
43. Dow L.K., Changela A., Hefner H.E., and Churchill M.E. Oxidation of a critical methionine modulates DNA binding of the Drosophila melanogaster high mobility group protein, HMG-D. FEBS Lett. 414 (1997) 514-520
44. Dunten R.L., and Cohen R.E. Recognition of modified forms of ribonuclease A by the ubiquitin system. J. Biol. Chem. 264 (1989) 16739-16747
45. Enserink M. Physiology or medicine. Triumph of the ulcer-bug theory. Science 310 (2005) 34-35
46. Esmon C.T. The roles of protein C and thrombomodulin in the regulation of blood coagulation. J. Biol. Chem. 264 (1989) 4743-4746
47. Ezraty B., Grimaud R., El Hassouni M., Moinier D., and Barras F. Methionine sulfoxide reductases protect Ffh from oxidative damages in Escherichia coli. EMBO J. 23 (2004) 1868-1877
48. Fielding C.J., and Fielding P.E. Molecular physiology of reverse cholesterol transport. J. Lipid Res. 36 (1995) 211-228
49. Frelinger III A.L., and Zull J.E. Oxidized forms of parathyroid hormone with biological activity. Separation and characterization of hormone forms oxidized at methionine 8 and methionine 18. J. Biol. Chem. 259 (1984) 5507-5513
50. Fuentes-Prior P., Iwanaga Y., Huber R., Pagila R., Rumennik G., Seto M., Morser J., Light D.R., and Bode W. Structural basis for the anticoagulant activity of the thrombin-thrombomodulin complex. Nature 404 (2000) 518-525
51. Gabbita S.P., Aksenov M.Y., Lovell M.A., and Markesbery W.R. Decrease in peptide methionine sulfoxide reductase in Alzheimer's disease brain. J. Neurochem. 73 (1999) 1660-1666
52. Gan Q.F., Witkop G.L., Sloane D.L., Straub K.M., and Sigal E. Identification of a specific methionine in mammalian 15-lipoxygenase which is oxygenated by the enzyme product 13-HPODE: Dissociation of sulfoxide formation from self-inactivation. Biochemistry 34 (1995) 7069-7079
53. Gao J., Yao Y., and Squier T.C. Oxidatively modified calmodulin binds to the plasma membrane Ca-ATPase in a nonproductive and conformationally disordered complex. Biophys. J. 80 (2001) 1791-1801
54. Giomarelli B., Visai L., Hijazi K., Rindi S., Ponzio M., Iannelli F., Speziale P., and Pozzi G. Binding of Streptococcus gordonii to extracellular matrix proteins. FEMS Microbiol. Lett. 265 (2006) 172-177
55. Gitlin G., Tsarbopoulos A., Patel S.T., Sydor W., Pramanik B.N., Jacobs S., Westreich L., Mittelman S., and Bausch J.N. Isolation and characterization of a monomethioninesulfoxide variant of interferon alpha-2b. Pharm. Res. 13 (1996) 762-769
56. Glaser C.B., and Li C.H. Reaction of bovine growth hormone with hydrogen peroxide. Biochemistry 13 (1974) 1044-1047
57. Glaser C.B., Karic L., Parmelee S., Premachandra B.R., Hinkston D., and Abrams W.R. Studies on the turnover of methionine oxidized alpha-1-protease inhibitor in rats. Am. Rev. Respir. Dis. 136 (1987) 857-861
58. Glaser C.B., Morser J., Clarke J.H., Blasko E., McLean K., Kuhn I., Chang R.J., Lin J.H., Vilander L., Andrews W.H., and Light D.R. Oxidation of a specific methionine in thrombomodulin by activated neutrophil products blocks cofactor activity. A potential rapid mechanism for modulation of coagulation. J. Clin. Invest. 90 (1992) 2565-2573
59. Glaser C.B., Yamin G., Uversky V.N., and Fink A.L. Methionine oxidation, alpha-synuclein and Parkinson's disease. Biochim. Biophys. Acta 1703 (2005) 157-169
60. Goedert M., and Spillantini M.G. A century of Alzheimer's disease. Science 314 (2006) 777-781
61. Gorlach A. Redox regulation of the coagulation cascade. Antioxid. Redox Signal. 7 (2005) 1398-1404
62. Guallar V., and Olsen B. The role of the heme propionates in heme biochemistry. J. Inorg. Biochem. 100 (2006) 755-760
63. Gustavsson N., Harndahl U., Emanuelsson A., Roepstorff P., and Sundby C. Methionine sulfoxidation of the chloroplast small heat shock protein and conformational changes in the oligomer. Protein Sci. 8 (1999) 2506-2512
64. Gustavsson N., Kokke B.P., Harndahl U., Silow M., Bechtold U., Poghosyan Z., Murphy D., Boelens W.C., and Sundby C. A peptide methionine sulfoxide reductase highly expressed in photosynthetic tissue in Arabidopsis thaliana can protect the chaperone-like activity of a chloroplast-localized small heat shock protein. Plant J. 29 (2002) 545-553
65. Harman D. Aging: A theory based on free radical and radiation chemistry. J. Gerontol. 11 (1956) 298-300
66. Harman D. Free radical theory of aging. Triangle 12 (1973) 153-158
67. Harndahl U., Kokke B.P., Gustavsson N., Linse S., Berggren K., Tjerneld F., Boelens W.C., and Sundby C. The chaperone-like activity of a small heat shock protein is lost after sulfoxidation of conserved methionines in a surface-exposed amphipathic alpha-helix. Biochim. Biophys. Acta 1545 (2001) 227-237
68. Henning R.J., and Sawmiller D.R. Vasoactive intestinal peptide: Cardiovascular effects. Cardiovasc. Res. 49 (2001) 27-37
69. Hill A.F., Joiner S., Wadsworth J.D., Sidle K.C., Bell J.E., Budka H., Ironside J.W., and Collinge J. Molecular classification of sporadic Creutzfeldt-Jakob disease. Brain 126 (2003) 1333-1346
70. Hou L., Kang I., Marchant R.E., and Zagorski M.G. Methionine 35 oxidation reduces fibril assembly of the amyloid abeta-(1-42) peptide of Alzheimer's disease. J. Biol. Chem. 277 (2002) 40173-40176
71. Houghten R.A., and Li C.H. Studies on pituitary prolactin. 39. Reaction of the ovine hormone with hydrogen peroxide. Biochim. Biophys. Acta 439 (1976) 240-249
72. Houghten R.A., Glaser C.B., and Li C.H. Human somatotropin. Reaction with hydrogen peroxide. Arch. Biochem. Biophys. 178 (1977) 350-355
73. Hsu Y.R., Narhi L.O., Spahr C., Langley K.E., and Lu H.S. In vitro methionine oxidation of Escherichia coli-derived human stem cell factor: Effects on the molecular structure, biological activity, and dimerization. Protein Sci. 5 (1996) 1165-1173
74. Ivanetich K.M., Bradshaw J.J., and Kaminsky L.S. Methionine sulfoxide cytochrome c. Biochemistry 15 (1976) 1144-1153
75. Jackson G.S., Hosszu L.L., Power A., Hill A.F., Kenney J., Saibil H., Craven C.J., Waltho J.P., Clarke A.R., and Collinge J. Reversible conversion of monomeric human prion protein between native and fibrilogenic conformations. Science 283 (1999) 1935-1937
76. Jacob C., Knight I., and Winyard P.G. Aspects of the biological redox chemistry of cysteine: From simple redox responses to sophisticated signalling pathways. Biol. Chem. 387 (2007) 1385-1397
77. Jia Y., Buehler P., Boykins R.A., Venable R.M., and Alayash A.I. Structural basis of peroxide mediated changes in human hemoglobin: A novel oxidative pathway. J. Biol. Chem. 282 (2007) 4894-4907
78. Jori G., Galiazzo G., Marzotto A., and Scoffone E. Selective and reversibe photo-oxidation of the methionyl residues in lysozyme. J. Biol. Chem. 243 (1968) 4272-4278
79. Jung B., Lee E.H., Chung W.S., Lee S.J., Shin S.H., Joo S.H., Kim S.K., and Lee J.H. Increased viability of PC12 cells exposed to amyloid-beta peptide by transduction with human TAT-methionine sulfoxide reductase. Neuroreport 14 (2003) 2349-2353
80. Kanayama A., Inoue J., Sugita-Konishi Y., Shimizu M., and Miyamoto Y. Oxidation of Ikappa Balpha at methionine 45 is one cause of taurine chloramine-induced inhibition of NF-kappa B activation. J. Biol. Chem. 277 (2002) 24049-24056
81. Karelson E., Fernaeus S., Reis K., Bogdanovic N., and Land T. Stimulation of G-proteins in human control and Alzheimer's disease brain by FAD mutants of APP(714-723): Implication of oxidative mechanisms. J. Neurosci. Res. 79 (2005) 368-374
82. Keck R.G. The use of t-butyl hydroperoxide as a probe for methionine oxidation in proteins. Anal. Biochem. 236 (1996) 56-62
83. Kedzierska S. [Role of Escherichia coli molecular chaperones in the protection of bacterial cells against irreversible aggregation induced by heat shock]. Postepy Biochem. 51 (2005) 146-153
84. Khor H.K., Fisher M.T., and Schoneich C. Potential role of methionine sulfoxide in the inactivation of the chaperone GroEL by hypochlorous acid (HOCl) and peroxynitrite (ONOO-). J. Biol. Chem. 279 (2004) 19486-19493
85. Kido K., and Kassell B. Oxidation of methionine residues of porcine and bovine pepsins. Biochemistry 14 (1975) 631-635
86. Kim H.Y., and Gladyshev V.N. Characterization of mouse endoplasmic reticulum methionine-R-sulfoxide reductase. Biochem. Biophys. Res. Commun. 320 (2004) 1277-1283
87. Kim K., and Erman J.E. Methionine modification in cytochrome-c peroxidase. Biochim. Biophys. Acta 954 (1988) 95-107
88. Kornfelt T., Persson E., and Palm L. Oxidation of methionine residues in coagulation factor VIIa. Arch. Biochem. Biophys. 363 (1999) 43-54
89. Kumar C.C., Nie H., Armstrong L., Zhang R., Vijay-Kumar S., and Tsarbopoulos A. Chloramine T-induced structural and biochemical changes in echistatin. FEBS Lett. 429 (1998) 239-248
90. Law R.H., Zhang Q., McGowan S., Buckle A.M., Silverman G.A., Wong W., Rosado C.J., Langendorf C.G., Pike R.N., Bird P.I., and Whisstock J.C. An overview of the serpin superfamily. Genome Biol. 7 (2006) 216.1-216.11
91. Lawrence D.A., and Loskutoff D.J. Inactivation of plasminogen activator inhibitor by oxidants. Biochemistry 25 (1986) 6351-6355
92. Lesage F., and Lazdunski M. Molecular and functional properties of two-pore-domain potassium channels. Am. J. Physiol. Renal Physiol. 279 (2000) F793-F801
93. Lev N., Roncevich D., Ickowicz D., Melamed E., and Offen D. Role of DJ-1 in Parkinson's disease. J. Mol. Neurosci. 29 (2006) 215-225
94. Levine R.L., Mosoni L., Berlett B.S., and Stadtman E.R. Methionine residues as endogenous antioxidants in proteins. Proc. Natl. Acad. Sci. USA 93 (1996) 15036-15040
95. Levine R.L., Moskovitz J., and Stadtman E.R. Oxidation of methionine in proteins: Roles in antioxidant defense and cellular regulation. IUBMB Life 50 (2000) 301-307
96. McCarthy J.B., Walker M., Pierce J., Camp P., and White J.D. Biosynthesis and metabolism of native and oxidized neuropeptide Y in the hippocampal mossy fiber system. J. Neurochem. 70 (1998) 1950-1963
97. Michaelis M.L., Bigelow D.J., Schoneich C., Williams T.D., Ramonda L., Yin D., Huhmer A.F., Yao Y., Gao J., and Squier T.C. Decreased plasma membrane calcium transport activity in aging brain. Life Sci. 59 (1996) 405-412
98. Midwinter R.G., Cheah F.C., Moskovitz J., Vissers M.C., and Winterbourn C.C. IkappaB is a sensitive target for oxidation by cell-permeable chloramines: Inhibition of NF-kappaB activity by glycine chloramine through methionine oxidation. Biochem. J. 396 (2006) 71-78
99. Miles A.M., and Smith R.L. Functional methionines in the collagen/gelatin binding domain of plasma fibronectin: Effects of chemical modification by chloramine T. Biochemistry 32 (1993) 8168-8178
100. Moraga F., and Janciauskiene S. Activation of primary human monocytes by the oxidized form of alpha1-antitrypsin. J. Biol. Chem. 275 (2000) 7693-7700
101. Moreno J.J. Antiflammin peptides in the regulation of inflammatory response. Ann. N Y Acad. Sci. 923 (2000) 147-153
102. Moskovitz J. Methionine sulfoxide reductases: Ubiquitous enzymes involved in antioxidant defense, protein regulation, and prevention of aging-associated diseases. Biochim. Biophys. Acta 1703 (2005) 213-219
103. Moskovitz J. Roles of methionine suldfoxide reductases in antioxidant defense, protein regulation and survival. Curr. Pharm. Des. 11 (2005) 1451-1457
104. Moskovitz J., and Bush A.I. Methionine sulfoxide reductase system: Possible roles in protection against neurodegenerative diseases. In: Luo Y., and Packer L. (Eds). "Oxidative Stress and Age-Related Neurodegeneration" (2005), CRC, New York, NY 197-210
105. Moskovitz J., Jenkins N.A., Gilbert D.J., Copeland N.G., Jursky F., Weissbach H., and Brot N. Chromosomal localization of the mammalian peptide-methionine sulfoxide reductase gene and its differential expression in various tissues. Proc. Natl. Acad. Sci. USA 93 (1996) 3205-3208
106. Moskovitz J., Poston J.M., Berlett B.S., Nosworthy N.J., Szczepanowski R., and Stadtman E.R. Identification and characterization of a putative active site for peptide methionine sulfoxide reductase (MsrA) and its substrate stereospecificity. J. Biol. Chem. 275 (2000) 14167-14172
107. Moskovitz J., Bar-Noy S., Williams W.M., Requena J., Berlett B.S., and Stadtman E.R. Methionine sulfoxide reductase (MsrA) is a regulator of antioxidant defense and lifespan in mammals. Proc. Natl. Acad. Sci. USA 98 (2001) 12920-12925
108. Moskovitz J., Singh V.K., Requena J., Wilkinson B.J., Jayaswal R.K., and Stadtman E.R. Purification and characterization of methionine sulfoxide reductases from mouse and Staphylococcus aureus and their substrate stereospecificity. Biochem. Biophys. Res. Commun. 290 (2002) 62-65
109. Mutt V. Additional observations on cholecystokinin and the vasoactive intestinal polypeptide. Peptides 2 Suppl. 2 (1981) 209-214
110. Nabuchi Y., Fujiwara E., Ueno K., Kuboniwa H., Asoh Y., and Ushio H. Oxidation of recombinant human parathyroid hormone: Effect of oxidized position on the biological activity. Pharm. Res. 12 (1995) 2049-2052
111. Nabuchi Y., Asoh Y., and Takayama M. Folding analysis of hormonal polypeptide calcitonins and the oxidized calcitonins using electrospray ionization mass spectrometry combined with H/D exchange. J. Am. Soc. Mass Spectrom. 15 (2004) 1556-1564
112. Nishimura C., Ekida T., Masuda S., Futatsugi K., Itoh S., Yasukawa K., Kishimoto T., and Arata Y. Chemical modification and 1H-NMR studies on the receptor-binding region of human interleukin 6. Eur. J. Biochem. 196 (1991) 377-384
113. Oda T., and Tokushige M. Chemical modification of tryptophanase by chloramine T: A possible involvement of the methionine residue in enzyme activity. J. Biochem. (Tokyo) 104 (1988) 178-183
114. Panzenbock U., and Stocker R. Formation of methionine sulfoxide-containing specific forms of oxidized high-density lipoproteins. Biochim. Biophys. Acta 1703 (2005) 171-181
115. Pennathur S., Bergt C., Shao B., Byun J., Kassim S.Y., Singh P., Green P.S., McDonald T.O., Brunzell J., Chait A., Oram J.F., O'Brien K., et al. Human atherosclerotic intima and blood of patients with established coronary artery disease contain high density lipoprotein damaged by reactive nitrogen species. J. Biol. Chem. 279 (2004) 42977-42983
116. Pennings M., Meurs I., Ye D., Out R., Hoekstra M., Van Berkel T.J., and Van Eck M. Regulation of cholesterol homeostasis in macrophages and consequences for atherosclerotic lesion development. FEBS Lett. 580 (2006) 5588-5596
117. Petropoulos I., Mary J., Perichon M., and Friguet B. Rat peptide methionine sulphoxide reductase: Cloning of the cDNA, and down-regulation of gene expression and enzyme activity during aging. Biochem. J. 355 (2001) 819-825
118. Pogocki D. Alzheimer's beta-amyloid peptide as a source of neurotoxic free radicals: The role of structural effects. Acta Neurobiol. Exp. (Wars.) 63 (2003) 131-145
119. Rachidi W., Vilette D., Guiraud P., Arlotto M., Riondel J., Laude H., Lehmann S., and Favier A. Expression of prion protein increases cellular copper binding and antioxidant enzyme activities but not copper delivery. J. Biol. Chem. 278 (2003) 9064-9072
120. Rapoport S., Hartel B., and Hausdorf G. Methionine sulfoxide formation: The cause of self-inactivation of reticulocyte lipoxygenase. Eur. J. Biochem. 139 (1984) 573-576
121. Ray Jr. W.J., Latham Jr. H.G., Katsoulis M., and Koshland Jr. D.E. Evidence for involvement of a methionine residue in the enzymatic action of phosphoglucomutase and chymotrypsin. J. Am. Chem. Soc. 82 (1960) 4743-4744
122. Reddy V.Y., Desorchers P.E., Pizzo S.V., Gonias S.L., Sahakian J.A., Levine R.L., and Weiss S.J. Oxidative dissociation of human alpha 2-macroglobulin tetramers into dysfunctional dimers. J. Biol. Chem. 269 (1994) 4683-4691
123. Reis K., Zharkovsky A., Bogdanovic N., Karelson E., and Land T. Critical role of methionine-722 in the stimulation of human brain G-proteins and neurotoxicity induced by London familial Alzheimer's disease (FAD) mutated V717G-APP(714-723). Neuroscience 144 (2007) 571-578
124. Rudolphus A., Heinzel-Wieland R., Vincent V.A., Saunders D., Steffens G.J., Dijkman J.H., and Kramps J.A. Oxidation-resistant variants of recombinant antileucoprotease are better inhibitors of human-neutrophil-elastase-induced emphysema in hamsters than natural recombinant antileucoprotease. Clin. Sci. (Lond.) 81 (1991) 777-784
125. Sagher D., Brunell D., Brot N., Vallee B.L., and Weissbach H. Selenocompounds can serve as oxidoreductants with the methionine sulfoxide reductase enzymes. J. Biol. Chem. 281 (2006) 31184-31187
126. Sagher D., Brunell D., Hejtmancik J.F., Kantorow M., Brot N., and Weissbach H. Thionein can serve as a reducing agent for the methionine sulfoxide reductases. Proc. Natl. Acad. Sci. USA 103 (2006) 8656-8661
127. + channels. J. Physiol. 571 (2006) 329-348
128. Sattler W., Maiorino M., and Stocker R. Reduction of HDL- and LDL-associated cholesterylester and phospholipid hydroperoxides by phospholipid hydroperoxide glutathione peroxidase and Ebselen (PZ 51). Arch. Biochem. Biophys. 309 (1994) 214-221
129. Savige W.E., and Fontana A. Interconversion of methionine and methionine sulfoxide. Methods Enzymol. 47 (1977) 453-459
130. Shao B., Oda M.N., Bergt C., Fu X., Green P.S., Brot N., Oram J.F., and Heinecke J.W. Myeloperoxidase impairs ABCA1-dependent cholesterol efflux through methionine oxidation and site-specific tyrosine chlorination of apolipoprotein A-I. J. Biol. Chem. 281 (2006) 9001-9004
131. Shechter Y., Burnstein Y., and Gertler A. Effect of oxidation of methionine residues in chicken ovoinhibitor on its inhibitory activities against trypsin, chymotrypsin, and elastase. Biochemistry 16 (1977) 992-997
132. Sigalov A.B., and Stern L.J. Enzymatic repair of oxidative damage to human apolipoprotein A-I. FEBS Lett. 433 (1998) 196-200
133. Smith C.E., Stack M.S., and Johnson D.A. Ozone effects on inhibitors of human neutrophil proteinases. Arch. Biochem. Biophys. 253 (1987) 146-155
134. Sonne O., Larsen U.D., and Markussen J. The effect of oxidation of the Met27 residue of [125I]monoiodoglucagon on receptor-binding affinity. Hoppe Seylers Z. Physiol. Chem. 363 (1982) 95-101
135. Stadtman E.R., Moskovitz J., Berlett B.S., and Levine R.L. Cyclic oxidation and reduction of protein methionine residues is an important antioxidant mechanism. Mol. Cell. Biochem. 234-235 (2002) 3-9
136. Stauffer C.E., and Etson D. The effect on subtilisin activity of oxidizing a methionine residue. J. Biol. Chem. 244 (1969) 5333-5338
137. Stevens-Truss R., and Hinman C.L. Chemical modification of methionines in a cobra venom cytotoxin differentiates between lytic and binding domains. Toxicol. Appl. Pharmacol. 139 (1996) 234-242
138. Stief T.W., and Fareed J. The antithrombotic factor singlet oxygen/light (1O2/h nu). Clin. Appl. Thromb. Hemost. 6 (2000) 22-30
139. Stief T.W., Aab A., and Heimburger N. Oxidative inactivation of purified human alpha-2-antiplasmin, antithrombin III, and C1-inhibitor. Thromb. Res. 49 (1988) 581-589
140. Stief T.W., Martin E., Jimenez J., Digon J., and Rodriguez J.M. Effect of oxidants on proteases of the fibrinolytic system: Possible role for methionine residues in the interaction between tissue type plasminogen activator and fibrin. Thromb. Res. 61 (1991) 191-200
141. Sun H., Gao J., Ferrington D.A., Biesiada H., Williams T.D., and Squier T.C. Repair of oxidized calmodulin by methionine sulfoxide reductase restores ability to activate the plasma membrane Ca-ATPase. Biochemistry 38 (1999) 105-112
142. Sundby C., Harndahl U., Gustavsson N., Ahrman E., and Murphy D.J. Conserved methionines in chloroplasts. Biochim. Biophys. Acta 1703 (2005) 191-202
143. Swaim M.W., and Pizzo S.V. Methionine sulfoxide and the oxidative regulation of plasma proteinase inhibitors. J. Leukoc. Biol. 43 (1988) 365-379
144. Taggart C., Cervantes-Laurean D., Kim G., McElvaney N.G., Wehr N., Moss J., and Levine R.L. Oxidation of either methionine 351 or methionine 358 in alpha 1-antitrypsin causes loss of anti-neutrophil elastase activity. J. Biol. Chem. 275 (2000) 27258-27265
145. Tang X.D., Daggett H., Hanner M., Garcia M.L., McManus O.B., Brot N., Weissbach H., Heinemann S.H., and Hoshi T. Oxidative regulation of large conductance calcium-activated potassium channels. J. Gen. Physiol. 117 (2001) 253-274
146. Teh L.C., Murphy L.J., Huq N.L., Surus A.S., Friesen H.G., Lazarus L., and Chapman G.E. Methionine oxidation in human growth hormone and human chorionic somatomammotropin. Effects on receptor binding and biological activities. J. Biol. Chem. 262 (1987) 6472-6477
147. Tomb J.F., White O., Kerlavage A.R., Clayton R.A., Sutton G.G., Fleischmann R.D., Ketchum K.A., Klenk H.P., Gill S., Dougherty B.A., Nelson K., Quackenbush J., et al. The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature 388 (1997) 539-547
148. Trauner D., and Kramer R.H. Metabolic modulation of potassium channels. Sci. STKE 2004 (2004) pe22
149. Turkall R.M., Denison R.C., and Tsan M.F. Degradation and oxidation of methionine enkephalin by human neutrophils. J. Lab. Clin. Med. 99 (1982) 418-427
150. Uversky V.N., Gillespie J.R., and Fink A.L. Why are "natively unfolded" proteins unstructured under physiologic conditions?. Proteins 41 (2000) 415-427
151. Uversky V.N., Yamin G., Souillac P.O., Goers J., Glaser C.B., and Fink A.L. Methionine oxidation inhibits fibrillation of human alpha-synuclein in vitro. FEBS Lett. 517 (2002) 239-244
152. Van Patten S.M., Hanson E., Bernasconi R., Zhang K., Manavalan P., Cole E.S., McPherson J.M., and Edmunds T. Oxidation of methionine residues in antithrombin. Effects on biological activity and heparin binding. J. Biol. Chem. 274 (1999) 10268-10276
153. Vigna S.R., Giraud A.S., Reeve Jr. J.R., and Walsh J.H. Biological activity of oxidized and reduced iodinated bombesins. Peptides 9 (1988) 923-926
154. Vogt W., and Hesse D. Oxidants generated by the myeloperoxidase-halide system activate the fifth component of human complement, C5. Immunobiology 192 (1994) 1-9
155. Vogt W., Zimmermann B., Hesse D., and Nolte R. Activation of the fifth component of human complement, C5, without cleavage, by methionine oxidizing agents. Mol. Immunol. 29 (1992) 251-256
156. White C.E., Hunter M.J., Meininger D.P., White L.R., and Komives E.A. Large-scale expression, purification and characterization of small fragments of thrombomodulin: The roles of the sixth domain and of methionine 388. Protein Eng. 8 (1995) 1177-1187
157. Williams W.M., Stadtman E.R., and Moskovitz J. Ageing and exposure to oxidative stress in vivo differentially affect cellular levels of PrP in mouse cerebral microvessels and brain parenchyma. Neuropathol. Appl. Neurobiol. 30 (2004) 161-168
158. Wong B.S., Wang H., Brown D.R., and Jones I.M. Selective oxidation of methionine residues in prion proteins. Biochem. Biophys. Res. Commun. 259 (1999) 352-355
159. Wong B.S., Chen S.G., Colucci M., Xie Z., Pan T., Liu T., Li R., Gambetti P., Sy M.S., and Brown D.R. Aberrant metal binding by prion protein in human prion disease. J. Neurochem. 78 (2001) 1400-1408
160. Wood-Kaczmar A., Gandhi S., and Wood N.W. Understanding the molecular causes of Parkinson's disease. Trends Mol. Med. 12 (2006) 521-528
161. Wood M.J., Becvar L.A., Prieto J.H., Melacini G., and Komives E.A. NMR structures reveal how oxidation inactivates thrombomodulin. Biochemistry 42 (2003) 11932-11942
162. Wood M.J., Helena Prieto J., and Komives E.A. Structural and functional consequences of methionine oxidation in thrombomodulin. Biochim. Biophys. Acta 1703 (2005) 141-147
163. Yamin G., Glaser C.B., Uversky V.N., and Fink A.L. Certain metals trigger fibrillation of methionine-oxidized alpha-synuclein. J. Biol. Chem. 278 (2003) 27630-27635
164. Ye J.M., and Wolfe J.L. Oxidative degradation of antiflammin 2. Pharm. Res. 13 (1996) 250-255
165. Zheng L., Nukuna B., Brennan M.L., Sun M., Goormastic M., Settle M., Schmitt D., Fu X., Thomson L., Fox P.L., Ischiropoulos H., Smith J.D., et al. Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease. J. Clin. Invest. 114 (2004) 529-541
166. Zorin N.A., Zorina V.N., and Zorina R.M. [The role of macroglobulin family proteins in the regulation of inflammation]. Biomed. Khim. 52 (2006) 229-238